Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antroquinonol in Chronic Hepatitis B
NCT03625102Phase 2Completed
- Sponsor
- Golden Biotechnology Corporation
- Start
- Feb 2018
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antroquinonol in Chronic Hepatitis B (CHB), sponsored by Golden Biotechnology Corporation. Started Feb 2018; status: completed.
02
Drugs
antroquinonol
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03625102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03625102.